Hints and tips:
...It was a direct competitor to Tagamet, a big-selling drug produced by an American company, Smith Kline & French....
...Is Smith & Nephew the one that got away? The UK medical device maker has long been seen as a potential target for bigger US rivals....
...Beecham languished by comparison, later merging with Smith Kline and being subsequently subsumed within the GSK group....
...Dan Smith, who ended up being jailed for corruption, and Jeremy Beecham, recently sentenced to an infinitely more agreeable form of life imprisonment in the House of Lords....
...When he took charge of GlaxoSmithKline at the start of the decade, Jean-Pierre Garnier introduced a series of smaller “centres for excellence in drug discovery” focused on types of therapy....
...Mr Stout, who worked for Schering before joining GSK’s forerunner Smith Kline Beecham in 1996, was formally the boss of both Mr Witty and Mr Viehbacher, so his continued employment became more difficult...
...A few days later, instead of relaxing for the holidays, Mr Stéphenne, head of Smith Kline Biologicals, would be arguing for considerable investment from the full board of the parent company in the US, which...
...From 2000 I gradually ran down my holdings in drug companies, fortunately missing the big share price falls that happened in early 2002, which pretty much saw the halving of GlaxoSmith- Kline's share price...
International Edition